Christine E. MacBrayne

970 total citations
35 papers, 343 citations indexed

About

Christine E. MacBrayne is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Christine E. MacBrayne has authored 35 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Public Health, Environmental and Occupational Health and 11 papers in Epidemiology. Recurrent topics in Christine E. MacBrayne's work include Antibiotic Use and Resistance (9 papers), HIV/AIDS drug development and treatment (7 papers) and Streptococcal Infections and Treatments (6 papers). Christine E. MacBrayne is often cited by papers focused on Antibiotic Use and Resistance (9 papers), HIV/AIDS drug development and treatment (7 papers) and Streptococcal Infections and Treatments (6 papers). Christine E. MacBrayne collaborates with scholars based in United States, Brazil and United Kingdom. Christine E. MacBrayne's co-authors include Jennifer J. Kiser, Sarah K. Parker, Jason Child, Kelly Pearce, Amanda L. Hurst, Peter L. Anderson, Meghan Birkholz, Lane R. Bushman, James K. Todd and Joshua Blum and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

Christine E. MacBrayne

33 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine E. MacBrayne United States 13 126 101 79 70 55 35 343
Jane Minton United Kingdom 10 113 0.9× 103 1.0× 108 1.4× 69 1.0× 19 0.3× 21 336
Marina Esposito‐Farèse France 13 56 0.4× 208 2.1× 54 0.7× 107 1.5× 22 0.4× 21 552
Ayşe Batırel Türkiye 12 91 0.7× 204 2.0× 52 0.7× 63 0.9× 82 1.5× 43 427
Yi Xin Liew Singapore 12 40 0.3× 117 1.2× 55 0.7× 153 2.2× 43 0.8× 21 338
Birgir Jóhannsson United States 11 155 1.2× 218 2.2× 49 0.6× 164 2.3× 94 1.7× 22 493
İlhan Özgüneş Türkiye 9 98 0.8× 135 1.3× 29 0.4× 98 1.4× 41 0.7× 19 309
Eleni Mouloudi Greece 15 38 0.3× 175 1.7× 140 1.8× 97 1.4× 57 1.0× 44 662
Pérez Rodríguez Spain 12 126 1.0× 176 1.7× 121 1.5× 118 1.7× 25 0.5× 38 488
Anders Lannergård Sweden 10 60 0.5× 221 2.2× 31 0.4× 46 0.7× 80 1.5× 18 363
Wu Gong United States 11 108 0.9× 119 1.2× 90 1.1× 42 0.6× 12 0.2× 35 442

Countries citing papers authored by Christine E. MacBrayne

Since Specialization
Citations

This map shows the geographic impact of Christine E. MacBrayne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. MacBrayne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. MacBrayne more than expected).

Fields of papers citing papers by Christine E. MacBrayne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine E. MacBrayne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. MacBrayne. The network helps show where Christine E. MacBrayne may publish in the future.

Co-authorship network of co-authors of Christine E. MacBrayne

This figure shows the co-authorship network connecting the top 25 collaborators of Christine E. MacBrayne. A scholar is included among the top collaborators of Christine E. MacBrayne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine E. MacBrayne. Christine E. MacBrayne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Sarah K., et al.. (2024). Preserving Resources: The Vital Role of Antimicrobial Stewardship Programs in Mitigating Antimicrobial Shortages. The Joint Commission Journal on Quality and Patient Safety. 50(12). 893–896. 1 indexed citations
2.
MacBrayne, Christine E., Kelly Pearce, Diane Melara, et al.. (2024). Time to positivity of blood cultures in a level IV NICU varies based on organism category and population subgroups: is a 36-hour rule out safe?. Journal of Perinatology. 44(12). 1807–1815. 1 indexed citations
3.
Metjian, Talene A., et al.. (2024). At the break point: What needs to change for antimicrobial stewardship program pharmacists?. American Journal of Health-System Pharmacy. 81(24). 1322–1326. 1 indexed citations
4.
Birkholz, Meghan, Kristen Miller, Christine E. MacBrayne, et al.. (2024). Clinical Impact of Pleural Fluid Streptococcus pneumoniae Polymerase Chain Reaction Testing in Children With Complicated Pneumonia. Clinical Infectious Diseases. 79(6). 1487–1494. 6 indexed citations
5.
MacBrayne, Christine E., et al.. (2023). Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 70(11). e30608–e30608. 14 indexed citations
6.
MacBrayne, Christine E., et al.. (2022). Identifying predictors for source culture positivity in children with acute musculoskeletal infections. Diagnosis. 9(3). 359–363.
7.
MacBrayne, Christine E., Richard M. Rutstein, Andrew Wiznia, et al.. (2021). Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. AIDS. 35(9). 1413–1421. 2 indexed citations
8.
MacBrayne, Christine E., et al.. (2021). A Multidisciplinary Quality Improvement Initiative to Facilitate Penicillin Allergy Delabeling Among Hospitalized Pediatric Patients. Hospital Pediatrics. 11(5). 427–434. 24 indexed citations
9.
MacBrayne, Christine E., et al.. (2021). Impact of Antimicrobial Stewardship Bundle on Inpatient Use of Highly Bioavailable Antibacterials. Hospital Pediatrics. 11(5). 509–514. 1 indexed citations
10.
MacBrayne, Christine E., et al.. (2021). Time to Blood Culture Positivity by Pathogen and Primary Service. Hospital Pediatrics. 11(9). 953–961. 14 indexed citations
11.
MacBrayne, Christine E., et al.. (2020). Handshake antimicrobial stewardship as a model to recognize and prevent diagnostic errors. Diagnosis. 8(3). 347–352. 11 indexed citations
12.
Stein, Amy, et al.. (2020). 1332. Single Dose Oral Amoxicillin Challenge is a Safe and Effective Strategy to Delabel Penicillin Allergies among Low Risk Hospitalized Children. Open Forum Infectious Diseases. 7(Supplement_1). S677–S678. 2 indexed citations
13.
MacBrayne, Christine E., et al.. (2020). Inpatient Treatment of Acute Otitis Media at a Pediatric Hospital: A Missed Teaching Opportunity for Antimicrobial Stewardship. Hospital Pediatrics. 10(7). 615–619. 2 indexed citations
14.
Hurst, Amanda L., et al.. (2019). Hospital-wide Description of Clinical Indications for Pediatric Anti-infective Use. Clinical Therapeutics. 41(8). 1605–1611.e0. 8 indexed citations
15.
Child, Jason, Xinhui Chen, Rakesh D. Mistry, et al.. (2018). Pharmacokinetic and Pharmacodynamic Properties of Metronidazole in Pediatric Patients With Acute Appendicitis: A Prospective Study. Journal of the Pediatric Infectious Diseases Society. 8(4). 297–302. 13 indexed citations
16.
MacBrayne, Christine E., Kristen Marks, Daniel S. Fierer, et al.. (2018). Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. Journal of Antimicrobial Chemotherapy. 73(8). 2112–2119. 17 indexed citations
17.
Naggie, Susanna, Kristen Marks, Michael D. Hughes, et al.. (2017). Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C. Clinical Infectious Diseases. 64(8). 1035–1042. 28 indexed citations
18.
MacBrayne, Christine E. & Jennifer J. Kiser. (2016). Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV. Clinical Infectious Diseases. 63(suppl 1). S12–S23. 15 indexed citations
19.
MacBrayne, Christine E., Joshua Blum, & Jennifer J. Kiser. (2014). Tenofovir, Emtricitabine, and Darunavir/Ritonavir Pharmacokinetics in an HIV-Infected Patient After Roux-en-Y Gastric Bypass Surgery. Annals of Pharmacotherapy. 48(6). 816–819. 12 indexed citations
20.
Zheng, Jia‐Hua, et al.. (2013). Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry. Journal of Chromatography B. 944. 18–24. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Minton Breakdown of academic impact, for papers by Marina Esposito‐Farèse Breakdown of academic impact, for papers by Ayşe Batırel Breakdown of academic impact, for papers by Yi Xin Liew Breakdown of academic impact, for papers by Birgir Jóhannsson Breakdown of academic impact, for papers by İlhan Özgüneş Breakdown of academic impact, for papers by Eleni Mouloudi Breakdown of academic impact, for papers by Pérez Rodríguez Breakdown of academic impact, for papers by Anders Lannergård Breakdown of academic impact, for papers by Wu Gong
Rankless by CCL
2026